Orosomucoid as the accelerator of hepatic fibrosis.
Tsuneo Ozeki, M Kan, K. Iwaki, Kazuo Ohuchi
Abstract
Tsuneo Ozeki, M Kan, K. Iwaki, Kazuo Ohuchi
Abstract
The administration of orosomucoid to rats with chronic liver injury accelerated hepatic fibrosis. An increase of hepatic fibres was seen histologically and the content of hydroxyproline in the liver collagen fraction increased. Moreover, the incorporation of 3H-proline into the collagen fraction of injured liver was increased by the administration of orosomucoid.
OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The administration of orosomucoid to rats with chronic liver injury accelerated hepatic fibrosis. An increase of hepatic fibres was seen histologically and the content of hydroxyproline in the liver collagen fraction increased. Moreover, the incorporation of 3H-proline into the collagen fraction of injured liver was increased by the administration of orosomucoid.
Key concepts: Orosomucoid, Hydroxyproline, Fibrosis, Hepatic fibrosis, Medicine, Internal medicine, Chemistry, Pathology